Serum VEGF: Diagnostic Value of Acute Coronary Syndrome from Stable Angina Pectoris and Prognostic Value of Coronary Artery Disease
Table 1
Baseline characteristics of study population.
Control (n = 48)
CAD (n = 248)
value
Age (years)
61.15 ± 8.02
61.54 ± 8.36
0.705
Sex (n, male)
23 (47.9%)
105 (42.3%)
0.475
Hypertension (n, %)
0 (0%)
126 (73.3%)
NS
Diabetes mellitus (n, %)
0 (0%)
53 (30.8%)
NS
Smoking (n, %)
0 (0%)
89 (51.7%)
NS
HbA1c (%)
5.97 ± 0.68
6.35 ± 1.21
0.009
CK-MB (U/L)
9.2 (7.7, 11.4)
11.0 (9.0, 13.4)
0.003
TnI
0.003 (0.001, 0.008)
0.007 (0.003, 0.023)
<0.001
TC
4.73 (3.98, 5.38)
4.69 (4.09, 5.48)
0.860
TG
1.21 (1.00, 1.67)
1.51 (1.16, 2.04)
0.011
HDL-c
1.35 (1.13, 1.60)
1.17 (1.02, 1.35)
0.002
LDL-c (mg/dL)
3.05 ± 0.63
2.88 ± 0.68
0.086
Cr (mg/dL)
70.06 ± 5.75
71.95 ± 9.27
0.066
LVEF (%)
60.33 ± 3.61
59.14 ± 5.42
0.145
Gensini score
NS
38 (17, 74)
NS
PCI (n, %)
NS
100 (40.3%)
NS
VEGF (pg/mL)
160.93 (121.09, 303.26)
645.57 (319.48, 901.14)
<0.001
Date are expressed as mean ± SD (standard deviation), median (interquartile range), and absolute number (percentage). value for comparison between the CAD and the control group. . HbA1c: hemoglobin A1c; CK-MB: creatine kinase-MB; TnI: troponin I; TC: total cholesterol; TG: triglyceride; HDL-c: high-density lipoprotein cholesterol; LDL-c: low-density lipoprotein cholesterol; Cr = creatinine; LVEF: left ventricular ejection fraction; PCI: percutaneous coronary intervention; VEGF = vascular endothelial growth factor.
